A Study of the Effect of High-fat Meal on the Pharmacokinetics of Oral TQ-B3139 Capsules in Patients With Solid Tumor
Latest Information Update: 06 Dec 2022
At a glance
- Drugs Envonalkib (Primary)
- Indications Solid tumours
- Focus Pharmacokinetics
- Sponsors Chia Tai Tianqing Pharmaceutical Group
Most Recent Events
- 29 Mar 2021 Planned primary completion date changed from 1 Mar 2021 to 1 Mar 2022.
- 29 Mar 2021 Status changed from not yet recruiting to recruiting.
- 22 Dec 2020 New trial record